SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
Level 1, 200 Mary Street Brisbane QLD 4000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)The suspension of trading in the securities of Vectus Biosystems Limited will be lifted immediately following the release by VBS of an announcement regarding a material transaction in relation to a compound in the Vectus drug library. | 17/10/2025 |
The company has finalized a binding Term Sheet with XORTX Therapeutics for the sale of its VB4-P5 Renal Small Molecule Compound, targeting renal fibrosis. The deal, valued at US$3 million, includes shares and pre-funded warrants in XORTX. Vectus aims to retain an interest in VB4-P5's development while focusing on its cardiovascular candidate, VB0004, and ensuring no further financial contributions are needed for VB4-P5's commercialization. Closing is expected within 90 days. | 17/10/2025 |
The company's securities suspended pending announcement, as requested by VBS. | 17/10/2025 |
listed entity carried for record purposes only | 23/02/2016 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 27/05/2016 | Susan Pond | 21,500 | $1.380 | $29,670.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Maurie Stang | Non Exec Chairman, Deputy Chairman | 23/02/2016 |
| Linda Walters | Non Exec Director | 20/12/2024 |
| Ronald Shnier | Non Exec Director | 23/02/2016 |
| Susan Pond | Non Exec Director | 04/05/2016 |
| Robert Waring | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
